Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) Patients

Summary

This study will assess tolerability and safety and health outcomes in relapsing MS patients taking FTY720.

Timeline

Start

2010-05

Primary completion

2011-10

Completion

2011-10

Publications

• Results Gold R, Comi G, Palace J, Siever A, Gottschalk R, Bijarnia M, von Rosenstiel P, Tomic D, Kappos L; FIRST Study Investigators. Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study. J Neurol. 2014 Feb;261(2):267-76. doi: 10.1007/s00415-013-7115-8. Epub 2013 Nov 13.

Drugs

Indications